Abstract
We herein report the case of a young woman who was diagnosed with primary hyperparathyroidism and in whom genetic testing confirmed a diagnosis of hyperparathyroidism-jaw tumor syndrome. Familial hyperparathyroidism was suspected based on the patient’s young age at the onset of the disease. Thus, genetic testing was performed. It showed a germline mutation in the HRPT2/CDC73 gene and confirmed the diagnosis of hyperparathyroidism-jaw tumor syndrome. Total parathyroidectomy was performed to prevent recurrence. In patients with early-onset hyperparathyroidism, genetic testing should be considered to facilitate the selection of a proper surgical procedure based on the consideration of future life expectancy.
Author supplied keywords
Cite
CITATION STYLE
Koikawa, K., Okada, Y., Mori, H., Kawaguchi, M., Uchino, S., & Tanaka, Y. (2018). Hyperparathyroidism-jaw tumor syndrome confirmed by preoperative genetic testing. Internal Medicine, 57(6), 841–844. https://doi.org/10.2169/internalmedicine.9509-17
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.